Man Group’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$577K Buy
+39,532
New +$522K ﹤0.01% 2023
2025
Q3
Sell
-731,589
Closed -$11.7M 2249
2025
Q2
$11.7M Buy
731,589
+223,941
+44% +$3.99M 0.02% 716
2025
Q1
$9.86M Buy
507,648
+399,398
+369% +$8.41M 0.03% 736
2024
Q4
$2.38M Buy
+108,250
New +$2.08M 0.01% 1264
2024
Q3
Sell
-71,200
Closed -$851K 1997
2024
Q2
$851K Sell
71,200
-3,007
-4% -$33.6K ﹤0.01% 1551
2024
Q1
$822K Sell
74,207
-28,693
-28% -$293K ﹤0.01% 1621
2023
Q4
$891K Buy
+102,900
New +$800K ﹤0.01% 1489

Other funds holding CLBT

Man Group's CLBT Position: Q2 2026 in Review

Man Group opened a new position in Cellebrite (CLBT) in Q2 2026: 39,532 shares worth $577K. The stake represents ﹤0.01% of the portfolio and ranks #2023 among its holdings. This is a return to the name: Man Group previously reported a position in CLBT as recently as Q2 2025.

Man Group first reported a position in CLBT in Q4 2023 and has held it in 7 quarters since. The position peaked at $11.7M in Q2 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Man Group held 39,532 shares of Cellebrite worth $577K as of Q2 2026.
  • Cellebrite was a new Man Group position in Q2 2026.
  • Cellebrite made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2023 holding.
  • Man Group first reported a position in Cellebrite in Q4 2023 and has held it in 7 quarters since.
  • Man Group's Cellebrite position peaked at $11.7M in Q2 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.